Long-term pegylated interferon-α and its potential in the treatment of melanoma

by Reinhard Dummer, Joanna Mangana
Published 2009-04-01

Immunological effects of BRAF+MEK inhibition

by Paolo A. Ascierto, Reinhard Dummer
Published 2018-09-01

Hair Depigmentation and Hair Loss in Advanced Melanoma Treated with Combined Immunotherapy and Targeted Therapy

by Florentia Dimitriou, Joanna Mangana, Reinhard Dummer
Published 2020-01-01

Recurrent squamous cell carcinoma of the perianal skin: a case report

by Reinhard Dummer, Ramon Staeger, Egle Ramelyte
Published 2020-05-01

Innovative Therapeutic Approaches in Primary Cutaneous B Cell Lymphoma

by Claudia C. V. Lang, Claudia C. V. Lang, Egle Ramelyte, Egle Ramelyte, Reinhard Dummer, Reinhard Dummer
Published 2020-08-01

Flare-Up of Rheumatoid Arthritis by Anti-CTLA-4 Antibody but Not by Anti-PD1 Therapy in a Patient with Metastatic Melanoma

by Nicoletta F. Jaberg-Bentele, Michael Kunz, Shatha Abuhammad, Reinhard Dummer
Published 2017-03-01

Clinical and Molecular Features of Skin Malignancies in Muir-Torre Syndrome

by Dario Simic, Reinhard Dummer, Sandra N. Freiberger, Egle Ramelyte, Marjam-Jeanette Barysch
Published 2021-05-01

MEK inhibition and immune responses in advanced melanoma

by Reinhard Dummer, Egle Ramelyte, Sabrina Schindler, Olaf Thürigen, Mitchell P. Levesque, Peter Koelblinger
Published 2017-08-01

How I treat metastatic melanoma

by Reinhard Dummer, Joanna Mangana, Anna Lisa Frauchiger, Claudia Lang, Sara Micaletto, Marjam J. Barysch
Published 2019-05-01

432 3-year results of the phase 2 randomized trial for talimogene laherparepvec (T-VEC) neoadjuvant treatment plus surgery vs surgery in patients with resectable stage IIIB-IVM1a m...

by Merrick Ross, Reinhard Dummer, Lev Demidov, Edward Chan, David Gyorki, Robert Conry, Hoi-Shen Radcliffe
Published 2020-11-01

429 Long-term analysis of MASTERKEY-265 phase 1b trial of talimogene laherparepvec (T-VEC) plus pembrolizumab in patients with unresectable stage IIIB-IVM1c melanoma

by Antoni Ribas, Olivier Michielin, Reinhard Dummer, Scott Diede, Salvador Martin-Algarra, Sheryl Treichel, Edward Chan
Published 2020-11-01

Collection and preprocessing of fine needle aspirate patient samples for single cell profiling and data analysis

by Aizhan Tastanova, Egle Ramelyte, Zsolt Balázs, Ulrike Menzel, Christian Beisel, Michael Krauthammer, Reinhard Dummer, Mitchell Paul Levesque
Published 2021-06-01

Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden

by Melike Ak, Abdullah Kahraman, Fabian M. Arnold, Patrick Turko, Mitchell P. Levesque, Martin Zoche, Egle Ramelyte, Reinhard Dummer
Published 2021-06-01

Long–Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T–Cell Lymphoma; Results From a Single Institution Analysis

by Florentia Dimitriou, Florentia Dimitriou, Urs Schanz, Urs Schanz, Gayathri Nair, Gayathri Nair, Susanne Kimeswenger, Susanne Kimeswenger, Marie-Charlotte Brüggen, Marie-Charlotte Brüggen, Wolfram Hoetzenecker, Lars E. French, Reinhard Dummer, Reinhard Dummer, Antonio Cozzio, Antonio Cozzio, Emmanuella Guenova, Emmanuella Guenova, Emmanuella Guenova
Published 2020-06-01

Correction: RASopathic Skin Eruptions during Vemurafenib Therapy

by Jeannine D. Rinderknecht, Simone M. Goldinger, Sima Rozati, Jivko Kamarashev, Katrin Kerl, Lars E. French, Reinhard Dummer, Benedetta Belloni
Published 2013-01-01

Correction: RASopathic Skin Eruptions during Vemurafenib Therapy.

by Jeannine D. Rinderknecht, Simone M. Goldinger, Sima Rozati, Jivko Kamarashev, Katrin Kerl, Lars E. French, Reinhard Dummer, Benedetta Belloni
Published 2013-01-01

Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome)

by Joanna Mangana, Emmanuella Guenova, Katrin Kerl, Mirjana Urosevic-Maiwald, Valerie C. Amann, Cornelia Bayard, Reinhard Dummer, Lars E. French
Published 2017-03-01

RASopathic skin eruptions during vemurafenib therapy.

by Jeannine D Rinderknecht, Simone M Goldinger, Sima Rozati, Jivko Kamarashev, Katrin Kerl, Lars E French, Reinhard Dummer, Benedetta Belloni
Published 2013-01-01

Who’s Driving? Switch of Drivers in Immunotherapy-Treated Progressing Sinonasal Melanoma

by Sandra N. Freiberger, Patrick Turko, Martin Hüllner, Reinhard Dummer, Grégoire B. Morand, Mitchell P. Levesque, David Holzmann, Niels J. Rupp
Published 2021-05-01

A paracrine activin A–mDia2 axis promotes squamous carcinogenesis via fibroblast reprogramming

by Michael Cangkrama, Mateusz Wietecha, Nicolas Mathis, Rin Okumura, Luca Ferrarese, Dunja Al‐Nuaimi, Maria Antsiferova, Reinhard Dummer, Metello Innocenti, Sabine Werner
Published 2020-04-01